CAS 1616385-51-3

Formel: C19H17N5O

InChl: InChI=1S/C19H17N5O/c1-11-12(2)23-24-17(11)19(25)21-15-8-14-9-16(22-18(14)20-10-15)13-6-4-3-5-7-13/h3-10H,1-2H3,(H,20,22)(H,21,25)(H,23,24)

InChI Key: NVSHVYGIYPBTEZ-UHFFFAOYSA-N

SMILES: CC1=C(NN=C1C(=O)NC2=CN=C3C(=C2)C=C(N3)C4=CC=CC=C4)C

Bezuclastinib

CAS: 1616385-51-3

Bezuclastinib

Formel: C₁₉H₁₇N₅O

Reinheit: 99.5%

Molekulargewicht: 331.37

Ref: 54-BUP04184

Bezuclastinib

CAS: 1616385-51-3

Formel: C₁₉H₁₇N₅O

Farbe und Form: Solid

Molekulargewicht: 331.3712

Ref: IN-DA027JEP

Bezuclastinib

CAS: 1616385-51-3

4,5-Dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-3-carboxamide

Formel: C₁₉H₁₇N₅O

Reinheit: 98%

Molekulargewicht: 331.37

Ref: IN-DG01483355

Bezuclastinib

CAS: 1616385-51-3

Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.

Formel: C₁₉H₁₇N₅O

Reinheit: 99.55%

Farbe und Form: Solid

Molekulargewicht: 331.3712

Ref: TM-T60976